← Back to guidelines
Rheumatology35 papers

Discoid lupus erythematosus

Last edited: 4/15/2026

Overview

Discoid lupus erythematosus (DLE) is a chronic skin condition characterized by well-defined, erythematous, scaly plaques that can lead to scarring and potentially progress to systemic lupus erythematosus (SLE) 1.

Diagnosis

  • Clinical Features: Erythematous, raised, indurated papules or plaques, including rare periorbital localization 3.
  • Recommended Tests: Complete blood count with differential, urinalysis, complement levels (C3, C4), antinuclear antibodies (ANA), erythrocyte sedimentation rate (ESR), hepatic function tests, and renal function/electrolytes 1.
  • Classification Criteria: Ongoing development of 12 clinical and histopathologic items for formal classification criteria through expert consensus 2.
  • Management

  • First-Line Treatment: Hydroxychloroquine 1.
  • Adjunctive Treatments: Topical corticosteroids, antimalarials, and in severe cases, systemic corticosteroids or immunosuppressants (specific dosing not detailed in abstracts) 1.
  • Special Populations

  • Pediatrics: Consensus on screening labs including CBC, urinalysis, complement levels, ANA, ESR, hepatic function, and renal function/electrolytes; intensified evaluation for SLE if arthritis or nephritis develops 1.
  • Comorbidities: No specific recommendations provided for comorbidities like psoriasis affecting management 3.
  • Key Recommendations

  • Perform comprehensive screening labs including CBC, urinalysis, complement levels, ANA, ESR, hepatic function, and renal function/electrolytes in pediatric DLE patients (Evidence: Moderate 1).
  • Initiate hydroxychloroquine as first-line therapy for DLE (Evidence: Expert opinion 1).
  • Evaluate for SLE progression with intensified assessment if arthritis or nephritis is present (Evidence: Moderate 1).
  • Consider the development of formal DLE classification criteria based on expert consensus for improved diagnostic consistency (Evidence: Expert opinion 2).
  • References

    1 Arkin LM, Buhr K, Brandling-Bennett H, Chiu Y, Chong B, Curran M et al.. Practice-based differences in paediatric discoid lupus erythematosus. The British journal of dermatology 2019. link 2 Elman SA, Joyce C, Nyberg F, Furukawa F, Goodfield M, Hasegawa M et al.. Development of classification criteria for discoid lupus erythematosus: Results of a Delphi exercise. Journal of the American Academy of Dermatology 2017. link 3 Serarslan G, Atik E, Sarikaya G. Periorbital edema and erythema: an unusual localization of DLE in a patient with psoriasis. The Journal of dermatology 2011. link

    Original source

    1. [1]
      Practice-based differences in paediatric discoid lupus erythematosus.Arkin LM, Buhr K, Brandling-Bennett H, Chiu Y, Chong B, Curran M et al. The British journal of dermatology (2019)
    2. [2]
      Development of classification criteria for discoid lupus erythematosus: Results of a Delphi exercise.Elman SA, Joyce C, Nyberg F, Furukawa F, Goodfield M, Hasegawa M et al. Journal of the American Academy of Dermatology (2017)
    3. [3]
      Periorbital edema and erythema: an unusual localization of DLE in a patient with psoriasis.Serarslan G, Atik E, Sarikaya G The Journal of dermatology (2011)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG